Molecular pathogenesis of transplacentally induced mouse lung tumors. 1998

M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. msmiller@wfusmc.edu

Previous studies from this and other laboratories have shown that treatment of pregnant mice with 3-methylcholanthrene (MC) caused lung tumors in the offspring, the incidence of which correlated with fetal inducibility of Cyp1a1. Analysis of paraffin-embedded lung tissue for Ki-ras-2 mutations indicated that 79% of the lesions examined contained point mutations in codons 12 and 13 of the Ki-ras-2 gene locus, the majority of which (84%) were G-->T transversions. The mutational spectrum was dependent on the tumor stage, as both the incidence of mutation and type of mutation produced correlated with malignant progression of the tumor. Mutations occurred in 60% of the hyperplasias, 80% of the adenomas, and 100% of the adenocarcinomas. In the tumors with mutations, GLY12-->CYS12 transversions occurred in 100% of the hyperplasias, 42% of the adenomas, and 14% of the adenocarcinomas. GLY12-->VAL12 transversions were not observed in hyperplasias and occurred in 42% of the adenomas and 57% of the adenocarcinomas. The remaining ASP12 and ARG13 mutations occurred only in adenomas (17%) and adenocarcinomas (29%). The tumors were also analyzed for alterations in the structure or function of the tumor suppressor genes Rb, p53, and Cdkn2a. No mutations were observed in exons 5-8 of the p53 gene. SSCP analysis demonstrated that 2 of 15 lung tumors contained shifted bands at the Cdkn2a gene locus. Sequence analysis had identified these as mutations in exon 2, with a CAC-->TAC transition at base 301 (HIS74-->TYR74) in tumor 23-1 and GGG-->GAG transition at base 350 (GLY90-->GLU90) in tumor 36-1. Northern blot analysis of the larger tumors revealed that 14 of 14 of these large lung tumors exhibited markedly decreased expression of Rb gene transcripts. These results were confirmed by immunohistochemistry. The larger tumors, which exhibited features of adenocarcinomas, showed a marked reduction or almost complete absence of nuclear pRb staining compared with smaller adenomas and normal lung tissue. The results suggest that Ki-ras-2 mutations are an early and frequent event in lung tumorigenesis, and that the type of mutation produced by environmental chemicals can influence the carcinogenic potential of the tumor. The results obtained with the Cdkn2a and Rb genes suggest that alterations in the Rb regulatory axis may play a key role in the pathogenesis of the pulmonary tumors and appear to occur later in the neoplastic process. It appears from these experiments that the combination of mutated Ki-ras-2 and alterations in the Rb regulatory gene locus, which are frequent alterations in human lung tumors, may be the preferred pathway for lung tumor pathogenesis in mice exposed transplacentally to environmental carcinogens.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1991, Experimental lung research,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
October 2001, Cancer letters,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
February 1981, Cancer letters,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1990, Proceedings of the National Academy of Sciences of the United States of America,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1972, Acta neuropathologica,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1992, Molecular carcinogenesis,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1989, Pediatric pathology,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1981, Acta neuropathologica. Supplementum,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
January 1988, Cancer research,
M S Miller, and S Leone-Kabler, and L A Rollins, and L L Wessner, and M Fan, and D O Schaeffer, and M F McEntee, and M G O'Sullivan
March 2013, Molecular cancer,
Copied contents to your clipboard!